Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,085 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial.
Eitel I, Wöhrle J, Suenkel H, Meissner J, Kerber S, Lauer B, Pauschinger M, Birkemeyer R, Axthelm C, Zimmermann R, Neuhaus P, Brosteanu O, de Waha S, Desch S, Gutberlet M, Schuler G, Thiele H. Eitel I, et al. Among authors: zimmermann r. J Am Coll Cardiol. 2013 Apr 2;61(13):1447-54. doi: 10.1016/j.jacc.2013.01.048. Epub 2013 Feb 27. J Am Coll Cardiol. 2013. PMID: 23466078 Free article. Clinical Trial.
Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention: design and rationale of the Abciximab Intracoronary versus intravenously Drug Application in ST-Elevation Myocardial Infarction (AIDA STEMI) trial.
Thiele H, Wöhrle J, Neuhaus P, Brosteanu O, Sick P, Prondzinsky R, Birkemeyer R, Wiemer M, Kerber S, Schuehlen H, Kleinertz K, Axthelm C, Zimmermann R, Rittger H, Braun-Dullaeus RC, Lauer B, Burckhardt W, Ferrari M, Bergmann MW, Hambrecht R, Schuler G; Abciximab Intracoronary versus intravenously Drug Application in ST-Elevation Myocardial Infarction (AIDA STEMI) Investigators. Thiele H, et al. Among authors: zimmermann r. Am Heart J. 2010 Apr;159(4):547-54. doi: 10.1016/j.ahj.2009.12.038. Am Heart J. 2010. PMID: 20362711 Clinical Trial.
Prognostic relevance of papillary muscle infarction in reperfused infarction as visualized by cardiovascular magnetic resonance.
Eitel I, Gehmlich D, Amer O, Wöhrle J, Kerber S, Lauer B, Pauschinger M, Schwab J, Birkemeyer R, Zimmermann R, Mende M, de Waha S, Desch S, Gutberlet M, Schuler G, Thiele H. Eitel I, et al. Among authors: zimmermann r. Circ Cardiovasc Imaging. 2013 Nov;6(6):890-8. doi: 10.1161/CIRCIMAGING.113.000411. Epub 2013 Aug 23. Circ Cardiovasc Imaging. 2013. PMID: 23973868 Clinical Trial.
Progress and challenges in the elimination of hepatitis C among people who inject drugs in Germany: results of a pilot study for a national monitoring system, 10 years after the first data collection.
Steffen G, Krings A, Guttmann S, Lübke N, Meyer-Schlinkmann K, Tiemann C, Timm J, Walker A, Zimmermann R; DRUCK 2.0-study group. Steffen G, et al. Among authors: zimmermann r. Harm Reduct J. 2024 Dec 20;21(1):222. doi: 10.1186/s12954-024-01119-2. Harm Reduct J. 2024. PMID: 39707505 Free PMC article.
Comprehensive elemental and physical characterization of vehicle brake wear emissions from two different brake pads following the Global Technical Regulation methodology.
Neukirchen C, Saraji-Bozorgzad MR, Mäder M, Mudan AP, Czasch P, Becker J, Di Bucchianico S, Trapp C, Zimmermann R, Adam T. Neukirchen C, et al. Among authors: zimmermann r. J Hazard Mater. 2024 Nov 20;482:136609. doi: 10.1016/j.jhazmat.2024.136609. Online ahead of print. J Hazard Mater. 2024. PMID: 39591789 Free article.
How far are we? Assessing progress in hepatitis C response towards the WHO 2030 elimination goals by the civil society monitoring in 25 European countries, period 2020 to 2023.
Maticic M, Cernosa J, Loboda C, Tamse J, Rigoni R, Duffell E, Indave I, Zimmermann R, Darragh L, Moura J, Leicht A, Windelinckx T, Jauffret-Roustide M, Schiffer K, Tammi T. Maticic M, et al. Among authors: zimmermann r. Harm Reduct J. 2024 Nov 20;21(1):203. doi: 10.1186/s12954-024-01115-6. Harm Reduct J. 2024. PMID: 39563360 Free PMC article.
Functionally overlapping intra- and extralysosomal pathways promote bis(monoacylglycero)phosphate synthesis in mammalian cells.
Bulfon D, Breithofer J, Grabner GF, Fawzy N, Pirchheim A, Wolinski H, Kolb D, Hartig L, Tischitz M, Zitta C, Bramerdorfer G, Lass A, Taschler U, Kratky D, Greimel P, Zimmermann R. Bulfon D, et al. Among authors: zimmermann r. Nat Commun. 2024 Nov 16;15(1):9937. doi: 10.1038/s41467-024-54213-1. Nat Commun. 2024. PMID: 39548099 Free PMC article.
2,085 results